| AR | EN
National Node of the BCH
Egyptian Biosafety Clearing House > Record details
Capacity Building Activities, Projects and Opportunities
Record information and status
Record ID
5106
Status
Published
Date of creation
2004-02-11 14:44 UTC (dubravka.stepic@biodiv.org)
Date of last update
2010-01-11 12:41 UTC (intern.ross.carroll@cbd.int)
Date of publication
2010-01-11 12:41 UTC (intern.ross.carroll@cbd.int)

General information
Title of the initiative
European Commission International Cooperative Programme (INCO)
Contact person
Mr. Christoph Bail
Head of Unit
European Commission
Directorate General XI; Environment, Nuclear Safety and Civil ProtectionEuropean Commission200, rue de la LoiB-1049 Bruxelles, Belgium
Phone:32-2-295-4099
Fax:32-2-296-9557
Email:christoph.bail@cec.eu.int
Url:http://europa.eu.int/comm/research/biot1.html
Beneficiary country(ies)
  • CBD Regional Groups - Africa
  • CBD Regional Groups - Latin America and the Caribbean
  • CBD Regional Groups - Asia and the Pacific
Type of initiative
Main target group(s) / beneficiaries
  • Target group: Developing countries
Start Date
1995-01-01
Ending date
1998-12-31
Donor(s) information
Agency(ies) or Organization(s) implementing or sponsoring the initiative (Additional Information)
  • Organization: European Commission (EC)
  • Type of Organization: Bilateral Donor Agency
  • Type of Organization: Regional Organization
Budget information
European Commission
Availability of funds for participants
Yes
Activity details
Description of the initiative
In 1995, the European Commision initiated the European Commission International Cooperative Programme (INCO) which included several activity areas relevant to biosafety. From 1995 to 1998, over 126 projects and activities related to biotechnology were financed by the European Union and carried out in cooperation with developing countries. This collaboration encompasses joint research projects, the organization of workshops for exchange of information on technical issues and policy matters, including regulations and product authorization procedures for GMOs. <BR>Capacity-building specifically targeted to biosafety includes funding for genetic resources and biosafety projects in Asia, Latin America, and Mediterranean countries and development of methodologies to assess and conserve biodiversity.

National level activities
Human-resources development
Information exchange & data management
Institutional strengthening
Scientific, technical and institutional collaboration

International level activities
International guidance
Strengthening of North-South and South-South Cooperation
Objective and main expected outcomes or lesson learned
Goals
To support countries in developing risk assessment and management
To concentrate on biotechnology applications for agriculture, health and natural resources management

Objectives
To support the sound management and use of biotechnology

Main outcomes
1) Over 126 projects/activities related to biotechnology were supported, from 1995 to 1998 . <BR>2) Approximately 200 post-doctoral fellowships in biotechnology for researchers from developing countries have been supported.
General thematic area(s)
  • Human resources capacity development and training
  • Scientific, technical and institutional collaboration at subregional, regional and international levels
  • Information exchange and data management including participation in the Biosafety Clearing-House
Convention on Biological Diversity | Central Portal of the Biosafety Clearing-House